nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RXRA—renal system—uterine cancer	0.00842	0.0622	CbGeAlD
Isotretinoin—RARA—myometrium—uterine cancer	0.00797	0.0588	CbGeAlD
Isotretinoin—RXRB—decidua—uterine cancer	0.00708	0.0523	CbGeAlD
Isotretinoin—RXRA—female reproductive system—uterine cancer	0.00675	0.0498	CbGeAlD
Isotretinoin—RARG—decidua—uterine cancer	0.00629	0.0464	CbGeAlD
Isotretinoin—RXRA—female gonad—uterine cancer	0.00614	0.0453	CbGeAlD
Isotretinoin—RARB—female reproductive system—uterine cancer	0.00606	0.0447	CbGeAlD
Isotretinoin—RARA—decidua—uterine cancer	0.00591	0.0436	CbGeAlD
Isotretinoin—RARA—renal system—uterine cancer	0.0058	0.0428	CbGeAlD
Isotretinoin—RARG—mammalian vulva—uterine cancer	0.00577	0.0426	CbGeAlD
Isotretinoin—RARA—endometrium—uterine cancer	0.00561	0.0414	CbGeAlD
Isotretinoin—RARB—female gonad—uterine cancer	0.00551	0.0407	CbGeAlD
Isotretinoin—RARG—uterus—uterine cancer	0.0055	0.0406	CbGeAlD
Isotretinoin—RARB—vagina—uterine cancer	0.00548	0.0404	CbGeAlD
Isotretinoin—RARA—uterus—uterine cancer	0.00517	0.0382	CbGeAlD
Isotretinoin—RXRB—female gonad—uterine cancer	0.00507	0.0374	CbGeAlD
Isotretinoin—RXRB—vagina—uterine cancer	0.00504	0.0372	CbGeAlD
Isotretinoin—RARG—female reproductive system—uterine cancer	0.00494	0.0365	CbGeAlD
Isotretinoin—RARA—female reproductive system—uterine cancer	0.00465	0.0343	CbGeAlD
Isotretinoin—RARG—female gonad—uterine cancer	0.0045	0.0332	CbGeAlD
Isotretinoin—RARG—vagina—uterine cancer	0.00447	0.033	CbGeAlD
Isotretinoin—RARA—female gonad—uterine cancer	0.00423	0.0312	CbGeAlD
Isotretinoin—RARB—lymph node—uterine cancer	0.00354	0.0262	CbGeAlD
Isotretinoin—RARG—lymph node—uterine cancer	0.00289	0.0213	CbGeAlD
Isotretinoin—RARA—lymph node—uterine cancer	0.00272	0.0201	CbGeAlD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—MET—uterine cancer	0.00189	0.00689	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptors—ESR2—uterine cancer	0.00186	0.00675	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00182	0.0066	CbGpPWpGaD
Isotretinoin—RARG—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.00181	0.00659	CbGpPWpGaD
Isotretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—NDUFB11—uterine cancer	0.00179	0.00652	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00178	0.00647	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—YWHAE—uterine cancer	0.00176	0.00639	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—CDH1—uterine cancer	0.00175	0.00635	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00172	0.00624	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00171	0.00621	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00171	0.00621	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.00167	0.00606	CbGpPWpGaD
Isotretinoin—RXRG—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.00166	0.00602	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00165	0.00598	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—CDH1—uterine cancer	0.00164	0.00597	CbGpPWpGaD
Isotretinoin—RARB—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.00162	0.00591	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—HMGA1—uterine cancer	0.00161	0.00585	CbGpPWpGaD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00159	0.00578	CbGpPWpGaD
Isotretinoin—RARA—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.00156	0.00566	CbGpPWpGaD
Isotretinoin—RXRB—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.00156	0.00566	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00153	0.00558	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—HMGA1—uterine cancer	0.00151	0.0055	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—ERBB2—uterine cancer	0.00147	0.00536	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.00147	0.00533	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—ERBB2—uterine cancer	0.00138	0.00504	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00129	0.00469	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—SOCS3—uterine cancer	0.0012	0.00438	CbGpPWpGaD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.00117	0.00425	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—SOCS3—uterine cancer	0.00113	0.00412	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptors—ESR1—uterine cancer	0.00113	0.00409	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.0011	0.004	CbGpPWpGaD
Isotretinoin—RARG—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.00109	0.00398	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.00106	0.00384	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—SMAD3—uterine cancer	0.00105	0.00383	CbGpPWpGaD
Isotretinoin—RXRG—Regulation of Androgen receptor activity—EP300—uterine cancer	0.00105	0.00382	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.00102	0.00371	CbGpPWpGaD
Isotretinoin—RXRG—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.001	0.00364	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—SMAD3—uterine cancer	0.000989	0.0036	CbGpPWpGaD
Isotretinoin—RXRB—Regulation of Androgen receptor activity—EP300—uterine cancer	0.000988	0.00359	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—MET—uterine cancer	0.000987	0.00359	CbGpPWpGaD
Isotretinoin—RARB—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.000982	0.00357	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000978	0.00356	CbGpPWpGaD
Isotretinoin—RXRA—REV-ERBA represses gene expression—EP300—uterine cancer	0.00097	0.00353	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000948	0.00345	CbGpPWpGaD
Isotretinoin—RARA—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.000941	0.00342	CbGpPWpGaD
Isotretinoin—RXRB—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.000941	0.00342	CbGpPWpGaD
Isotretinoin—RXRA—RORA activates circadian gene expression—EP300—uterine cancer	0.000939	0.00342	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000927	0.00337	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.000889	0.00323	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000888	0.00323	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—PIK3CA—uterine cancer	0.000886	0.00322	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—NFE2L2—uterine cancer	0.000881	0.0032	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—PHF1—uterine cancer	0.000871	0.00317	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000857	0.00312	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—CDH1—uterine cancer	0.000855	0.00311	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—GPX3—uterine cancer	0.00084	0.00306	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—PIK3CA—uterine cancer	0.000833	0.00303	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000831	0.00302	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—uterine cancer	0.00082	0.00298	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—EP300—uterine cancer	0.000812	0.00295	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PHF1—uterine cancer	0.000797	0.0029	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000796	0.0029	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—HMGA1—uterine cancer	0.000788	0.00287	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PHF1—uterine cancer	0.000781	0.00284	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—uterine cancer	0.000771	0.0028	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PLXNA3—uterine cancer	0.000763	0.00278	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PHF1—uterine cancer	0.000749	0.00272	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PHF1—uterine cancer	0.000749	0.00272	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—CHD4—uterine cancer	0.000741	0.00269	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—uterine cancer	0.000724	0.00263	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—uterine cancer	0.000722	0.00262	CbGpPWpGaD
Isotretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—uterine cancer	0.000686	0.0025	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP11A1—uterine cancer	0.000684	0.00249	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—uterine cancer	0.00068	0.00247	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—CHD4—uterine cancer	0.000677	0.00246	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—CHD4—uterine cancer	0.000664	0.00242	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—PGR—uterine cancer	0.000642	0.00233	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—CHD4—uterine cancer	0.000637	0.00232	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—CHD4—uterine cancer	0.000637	0.00232	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—SUZ12—uterine cancer	0.000621	0.00226	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000619	0.00225	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000607	0.00221	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000593	0.00216	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—SOCS3—uterine cancer	0.00059	0.00215	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—PGR—uterine cancer	0.000587	0.00214	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—PGR—uterine cancer	0.000576	0.00209	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—SUZ12—uterine cancer	0.000568	0.00206	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—ESR2—uterine cancer	0.000565	0.00206	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—SUZ12—uterine cancer	0.000557	0.00202	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—PGR—uterine cancer	0.000552	0.00201	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—PGR—uterine cancer	0.000552	0.00201	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—CTNNB1—uterine cancer	0.000551	0.00201	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.00055	0.002	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SUZ12—uterine cancer	0.000534	0.00194	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SUZ12—uterine cancer	0.000534	0.00194	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—CTNNB1—uterine cancer	0.000518	0.00189	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—ESR2—uterine cancer	0.000517	0.00188	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—SMAD3—uterine cancer	0.000516	0.00187	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—EP300—uterine cancer	0.000515	0.00187	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.00051	0.00185	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—ESR2—uterine cancer	0.000507	0.00184	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP19A1—uterine cancer	0.000503	0.00183	CbGpPWpGaD
Isotretinoin—RXRA—Circadian Clock—EP300—uterine cancer	0.0005	0.00182	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—uterine cancer	0.00049	0.00178	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—ESR2—uterine cancer	0.000486	0.00177	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—ESR2—uterine cancer	0.000486	0.00177	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000463	0.00168	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—CDKN2B—uterine cancer	0.00046	0.00167	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000454	0.00165	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000439	0.0016	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000439	0.0016	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000436	0.00158	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—uterine cancer	0.000434	0.00158	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000421	0.00153	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000421	0.00153	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—SMAD3—uterine cancer	0.00042	0.00153	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000418	0.00152	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000415	0.00151	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000413	0.0015	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000403	0.00147	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—uterine cancer	0.000402	0.00146	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HNF1B—uterine cancer	0.000401	0.00146	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000397	0.00145	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000396	0.00144	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000396	0.00144	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PHF1—uterine cancer	0.00039	0.00142	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000387	0.00141	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—SMAD3—uterine cancer	0.000384	0.0014	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—uterine cancer	0.000382	0.00139	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000381	0.00139	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—SMAD3—uterine cancer	0.000377	0.00137	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000371	0.00135	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000369	0.00134	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—SMAD3—uterine cancer	0.000361	0.00131	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—SMAD3—uterine cancer	0.000361	0.00131	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—uterine cancer	0.000355	0.00129	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000354	0.00129	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.00035	0.00127	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—ESR1—uterine cancer	0.000343	0.00125	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000335	0.00122	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—CHD4—uterine cancer	0.000332	0.00121	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000322	0.00117	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—ESR1—uterine cancer	0.000314	0.00114	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000309	0.00112	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—PGR—uterine cancer	0.000309	0.00112	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—ESR1—uterine cancer	0.000307	0.00112	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000297	0.00108	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—ESR1—uterine cancer	0.000295	0.00107	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—ESR1—uterine cancer	0.000295	0.00107	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—EZH2—uterine cancer	0.000294	0.00107	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—PGR—uterine cancer	0.000288	0.00105	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—EP300—uterine cancer	0.000287	0.00104	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000285	0.00104	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PGR—uterine cancer	0.000283	0.00103	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.000281	0.00102	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SUZ12—uterine cancer	0.000278	0.00101	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PGR—uterine cancer	0.000277	0.00101	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000273	0.000994	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—ESR2—uterine cancer	0.000272	0.00099	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NDUFB11—uterine cancer	0.000271	0.000984	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SRD5A2—uterine cancer	0.000271	0.000984	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—CTNNB1—uterine cancer	0.00027	0.000983	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—EZH2—uterine cancer	0.000268	0.000976	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PGR—uterine cancer	0.000266	0.000967	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PGR—uterine cancer	0.000266	0.000967	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000264	0.000962	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—EZH2—uterine cancer	0.000263	0.000958	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000263	0.000956	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000262	0.000953	CbGpPWpGaD
Isotretinoin—Blood creatinine increased—Doxorubicin—uterine cancer	0.000259	0.000439	CcSEcCtD
Isotretinoin—Asthma—Epirubicin—uterine cancer	0.000258	0.000438	CcSEcCtD
Isotretinoin—Dysphagia—Epirubicin—uterine cancer	0.000258	0.000438	CcSEcCtD
Isotretinoin—Dehydration—Doxorubicin—uterine cancer	0.000257	0.000436	CcSEcCtD
Isotretinoin—Thrombocytopenia—Etoposide—uterine cancer	0.000256	0.000435	CcSEcCtD
Isotretinoin—Tachycardia—Etoposide—uterine cancer	0.000255	0.000433	CcSEcCtD
Isotretinoin—Skin disorder—Etoposide—uterine cancer	0.000254	0.000431	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000253	0.000922	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—ESR2—uterine cancer	0.000253	0.000921	CbGpPWpGaD
Isotretinoin—Dry skin—Doxorubicin—uterine cancer	0.000253	0.000429	CcSEcCtD
Isotretinoin—Hyperhidrosis—Etoposide—uterine cancer	0.000253	0.000429	CcSEcCtD
Isotretinoin—Pancreatitis—Epirubicin—uterine cancer	0.000253	0.000429	CcSEcCtD
Isotretinoin—RARA—Gene Expression—EZH2—uterine cancer	0.000252	0.000918	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—EZH2—uterine cancer	0.000252	0.000918	CbGpPWpGaD
Isotretinoin—Anorexia—Etoposide—uterine cancer	0.000249	0.000423	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—ESR2—uterine cancer	0.000249	0.000905	CbGpPWpGaD
Isotretinoin—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000249	0.000422	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000248	0.000903	CbGpPWpGaD
Isotretinoin—Diarrhoea—Dactinomycin—uterine cancer	0.000247	0.00042	CcSEcCtD
Isotretinoin—Nasopharyngitis—Doxorubicin—uterine cancer	0.000247	0.000419	CcSEcCtD
Isotretinoin—Hypotension—Etoposide—uterine cancer	0.000245	0.000415	CcSEcCtD
Isotretinoin—Gastritis—Doxorubicin—uterine cancer	0.000244	0.000415	CcSEcCtD
Isotretinoin—RARB—Gene Expression—ESR2—uterine cancer	0.000244	0.000888	CbGpPWpGaD
Isotretinoin—Neutropenia—Epirubicin—uterine cancer	0.000241	0.000409	CcSEcCtD
Isotretinoin—Dysuria—Epirubicin—uterine cancer	0.000241	0.000409	CcSEcCtD
Isotretinoin—Abdominal distension—Doxorubicin—uterine cancer	0.00024	0.000408	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00024	0.000407	CcSEcCtD
Isotretinoin—Dysphagia—Doxorubicin—uterine cancer	0.000239	0.000405	CcSEcCtD
Isotretinoin—Asthma—Doxorubicin—uterine cancer	0.000239	0.000405	CcSEcCtD
Isotretinoin—Pollakiuria—Epirubicin—uterine cancer	0.000238	0.000404	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Epirubicin—uterine cancer	0.000235	0.000399	CcSEcCtD
Isotretinoin—Paraesthesia—Etoposide—uterine cancer	0.000235	0.000399	CcSEcCtD
Isotretinoin—Weight increased—Epirubicin—uterine cancer	0.000235	0.000398	CcSEcCtD
Isotretinoin—RARA—Gene Expression—ESR2—uterine cancer	0.000234	0.000851	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ESR2—uterine cancer	0.000234	0.000851	CbGpPWpGaD
Isotretinoin—Pancreatitis—Doxorubicin—uterine cancer	0.000234	0.000397	CcSEcCtD
Isotretinoin—Weight decreased—Epirubicin—uterine cancer	0.000233	0.000396	CcSEcCtD
Isotretinoin—Dyspnoea—Etoposide—uterine cancer	0.000233	0.000396	CcSEcCtD
Isotretinoin—Somnolence—Etoposide—uterine cancer	0.000233	0.000395	CcSEcCtD
Isotretinoin—Pneumonia—Epirubicin—uterine cancer	0.000231	0.000392	CcSEcCtD
Isotretinoin—Infestation—Epirubicin—uterine cancer	0.00023	0.00039	CcSEcCtD
Isotretinoin—Drowsiness—Epirubicin—uterine cancer	0.00023	0.00039	CcSEcCtD
Isotretinoin—Infestation NOS—Epirubicin—uterine cancer	0.00023	0.00039	CcSEcCtD
Isotretinoin—Vomiting—Dactinomycin—uterine cancer	0.00023	0.00039	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000228	0.000387	CcSEcCtD
Isotretinoin—Rash—Dactinomycin—uterine cancer	0.000228	0.000387	CcSEcCtD
Isotretinoin—Decreased appetite—Etoposide—uterine cancer	0.000227	0.000386	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000227	0.000826	CbGpPWpGaD
Isotretinoin—Renal failure—Epirubicin—uterine cancer	0.000226	0.000383	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000226	0.000383	CcSEcCtD
Isotretinoin—Fatigue—Etoposide—uterine cancer	0.000226	0.000383	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Epirubicin—uterine cancer	0.000225	0.000382	CcSEcCtD
Isotretinoin—Stomatitis—Epirubicin—uterine cancer	0.000224	0.00038	CcSEcCtD
Isotretinoin—Pain—Etoposide—uterine cancer	0.000224	0.00038	CcSEcCtD
Isotretinoin—Constipation—Etoposide—uterine cancer	0.000224	0.00038	CcSEcCtD
Isotretinoin—Urinary tract infection—Epirubicin—uterine cancer	0.000224	0.000379	CcSEcCtD
Isotretinoin—Conjunctivitis—Epirubicin—uterine cancer	0.000224	0.000379	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000223	0.000812	CbGpPWpGaD
Isotretinoin—Neutropenia—Doxorubicin—uterine cancer	0.000223	0.000379	CcSEcCtD
Isotretinoin—Dysuria—Doxorubicin—uterine cancer	0.000223	0.000379	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000222	0.000376	CcSEcCtD
Isotretinoin—RARG—Gene Expression—CDKN2B—uterine cancer	0.000222	0.000806	CbGpPWpGaD
Isotretinoin—Sweating—Epirubicin—uterine cancer	0.00022	0.000374	CcSEcCtD
Isotretinoin—Pollakiuria—Doxorubicin—uterine cancer	0.00022	0.000374	CcSEcCtD
Isotretinoin—Haematuria—Epirubicin—uterine cancer	0.000219	0.000372	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000218	0.00037	CcSEcCtD
Isotretinoin—Weight increased—Doxorubicin—uterine cancer	0.000217	0.000368	CcSEcCtD
Isotretinoin—Epistaxis—Epirubicin—uterine cancer	0.000217	0.000368	CcSEcCtD
Isotretinoin—Weight decreased—Doxorubicin—uterine cancer	0.000216	0.000366	CcSEcCtD
Isotretinoin—Sinusitis—Epirubicin—uterine cancer	0.000216	0.000366	CcSEcCtD
Isotretinoin—Feeling abnormal—Etoposide—uterine cancer	0.000216	0.000366	CcSEcCtD
Isotretinoin—Nausea—Dactinomycin—uterine cancer	0.000215	0.000364	CcSEcCtD
Isotretinoin—Agranulocytosis—Epirubicin—uterine cancer	0.000215	0.000364	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000214	0.000778	CbGpPWpGaD
Isotretinoin—Pneumonia—Doxorubicin—uterine cancer	0.000214	0.000363	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Etoposide—uterine cancer	0.000214	0.000363	CcSEcCtD
Isotretinoin—Drowsiness—Doxorubicin—uterine cancer	0.000213	0.000361	CcSEcCtD
Isotretinoin—Infestation—Doxorubicin—uterine cancer	0.000213	0.000361	CcSEcCtD
Isotretinoin—Infestation NOS—Doxorubicin—uterine cancer	0.000213	0.000361	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000211	0.000358	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.00021	0.000765	CbGpPWpGaD
Isotretinoin—Renal failure—Doxorubicin—uterine cancer	0.000209	0.000355	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000209	0.000354	CcSEcCtD
Isotretinoin—Urticaria—Etoposide—uterine cancer	0.000208	0.000353	CcSEcCtD
Isotretinoin—Haemoglobin—Epirubicin—uterine cancer	0.000208	0.000352	CcSEcCtD
Isotretinoin—Stomatitis—Doxorubicin—uterine cancer	0.000207	0.000352	CcSEcCtD
Isotretinoin—Body temperature increased—Etoposide—uterine cancer	0.000207	0.000351	CcSEcCtD
Isotretinoin—Abdominal pain—Etoposide—uterine cancer	0.000207	0.000351	CcSEcCtD
Isotretinoin—Urinary tract infection—Doxorubicin—uterine cancer	0.000207	0.000351	CcSEcCtD
Isotretinoin—Conjunctivitis—Doxorubicin—uterine cancer	0.000207	0.000351	CcSEcCtD
Isotretinoin—Haemorrhage—Epirubicin—uterine cancer	0.000206	0.00035	CcSEcCtD
Isotretinoin—Hepatitis—Epirubicin—uterine cancer	0.000206	0.00035	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000206	0.00075	CbGpPWpGaD
Isotretinoin—Hypoaesthesia—Epirubicin—uterine cancer	0.000205	0.000348	CcSEcCtD
Isotretinoin—Pharyngitis—Epirubicin—uterine cancer	0.000205	0.000348	CcSEcCtD
Isotretinoin—Sweating—Doxorubicin—uterine cancer	0.000204	0.000346	CcSEcCtD
Isotretinoin—Urinary tract disorder—Epirubicin—uterine cancer	0.000204	0.000346	CcSEcCtD
Isotretinoin—Oedema peripheral—Epirubicin—uterine cancer	0.000203	0.000345	CcSEcCtD
Isotretinoin—Haematuria—Doxorubicin—uterine cancer	0.000203	0.000344	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—CDKN2B—uterine cancer	0.000203	0.000737	CbGpPWpGaD
Isotretinoin—Urethral disorder—Epirubicin—uterine cancer	0.000202	0.000343	CcSEcCtD
Isotretinoin—RARG—Gene Expression—SMAD3—uterine cancer	0.000202	0.000736	CbGpPWpGaD
Isotretinoin—Epistaxis—Doxorubicin—uterine cancer	0.000201	0.00034	CcSEcCtD
Isotretinoin—Sinusitis—Doxorubicin—uterine cancer	0.0002	0.000339	CcSEcCtD
Isotretinoin—Visual impairment—Epirubicin—uterine cancer	0.000199	0.000337	CcSEcCtD
Isotretinoin—RARB—Gene Expression—CDKN2B—uterine cancer	0.000199	0.000723	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000199	0.000722	CbGpPWpGaD
Isotretinoin—Agranulocytosis—Doxorubicin—uterine cancer	0.000199	0.000337	CcSEcCtD
Isotretinoin—RXRA—Metabolism—AKR1B1—uterine cancer	0.000196	0.000711	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—STAR—uterine cancer	0.000196	0.000711	CbGpPWpGaD
Isotretinoin—Erythema multiforme—Epirubicin—uterine cancer	0.000195	0.000331	CcSEcCtD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000194	0.000704	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000194	0.000704	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000193	0.000703	CbGpPWpGaD
Isotretinoin—Eye disorder—Epirubicin—uterine cancer	0.000193	0.000327	CcSEcCtD
Isotretinoin—Hypersensitivity—Etoposide—uterine cancer	0.000193	0.000327	CcSEcCtD
Isotretinoin—Tinnitus—Epirubicin—uterine cancer	0.000192	0.000327	CcSEcCtD
Isotretinoin—Haemoglobin—Doxorubicin—uterine cancer	0.000192	0.000326	CcSEcCtD
Isotretinoin—Flushing—Epirubicin—uterine cancer	0.000192	0.000325	CcSEcCtD
Isotretinoin—Haemorrhage—Doxorubicin—uterine cancer	0.000191	0.000324	CcSEcCtD
Isotretinoin—Hepatitis—Doxorubicin—uterine cancer	0.000191	0.000324	CcSEcCtD
Isotretinoin—RARA—Gene Expression—CDKN2B—uterine cancer	0.00019	0.000693	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—CDKN2B—uterine cancer	0.00019	0.000693	CbGpPWpGaD
Isotretinoin—Hypoaesthesia—Doxorubicin—uterine cancer	0.00019	0.000322	CcSEcCtD
Isotretinoin—Pharyngitis—Doxorubicin—uterine cancer	0.00019	0.000322	CcSEcCtD
Isotretinoin—Urinary tract disorder—Doxorubicin—uterine cancer	0.000189	0.00032	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—SMAD3—uterine cancer	0.000188	0.000685	CbGpPWpGaD
Isotretinoin—Oedema peripheral—Doxorubicin—uterine cancer	0.000188	0.000319	CcSEcCtD
Isotretinoin—Asthenia—Etoposide—uterine cancer	0.000188	0.000318	CcSEcCtD
Isotretinoin—Angiopathy—Epirubicin—uterine cancer	0.000187	0.000318	CcSEcCtD
Isotretinoin—Urethral disorder—Doxorubicin—uterine cancer	0.000187	0.000318	CcSEcCtD
Isotretinoin—Chills—Epirubicin—uterine cancer	0.000185	0.000314	CcSEcCtD
Isotretinoin—Pruritus—Etoposide—uterine cancer	0.000185	0.000314	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—SMAD3—uterine cancer	0.000185	0.000673	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000185	0.000671	CbGpPWpGaD
Isotretinoin—Arrhythmia—Epirubicin—uterine cancer	0.000184	0.000313	CcSEcCtD
Isotretinoin—Visual impairment—Doxorubicin—uterine cancer	0.000184	0.000312	CcSEcCtD
Isotretinoin—Alopecia—Epirubicin—uterine cancer	0.000182	0.000309	CcSEcCtD
Isotretinoin—RARB—Gene Expression—SMAD3—uterine cancer	0.000181	0.00066	CbGpPWpGaD
Isotretinoin—Mental disorder—Epirubicin—uterine cancer	0.000181	0.000307	CcSEcCtD
Isotretinoin—Erythema multiforme—Doxorubicin—uterine cancer	0.000181	0.000306	CcSEcCtD
Isotretinoin—Malnutrition—Epirubicin—uterine cancer	0.00018	0.000305	CcSEcCtD
Isotretinoin—Erythema—Epirubicin—uterine cancer	0.00018	0.000305	CcSEcCtD
Isotretinoin—Diarrhoea—Etoposide—uterine cancer	0.000179	0.000304	CcSEcCtD
Isotretinoin—Eye disorder—Doxorubicin—uterine cancer	0.000179	0.000303	CcSEcCtD
Isotretinoin—Tinnitus—Doxorubicin—uterine cancer	0.000178	0.000302	CcSEcCtD
Isotretinoin—Flushing—Doxorubicin—uterine cancer	0.000177	0.000301	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—SMAD3—uterine cancer	0.000177	0.000644	CbGpPWpGaD
Isotretinoin—Flatulence—Epirubicin—uterine cancer	0.000177	0.0003	CcSEcCtD
Isotretinoin—Tension—Epirubicin—uterine cancer	0.000176	0.000299	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000175	0.000636	CbGpPWpGaD
Isotretinoin—Nervousness—Epirubicin—uterine cancer	0.000175	0.000296	CcSEcCtD
Isotretinoin—RARA—Gene Expression—SMAD3—uterine cancer	0.000174	0.000632	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SMAD3—uterine cancer	0.000174	0.000632	CbGpPWpGaD
Isotretinoin—Back pain—Epirubicin—uterine cancer	0.000174	0.000295	CcSEcCtD
Isotretinoin—Angiopathy—Doxorubicin—uterine cancer	0.000173	0.000294	CcSEcCtD
Isotretinoin—Dizziness—Etoposide—uterine cancer	0.000173	0.000294	CcSEcCtD
Isotretinoin—Chills—Doxorubicin—uterine cancer	0.000171	0.000291	CcSEcCtD
Isotretinoin—Arrhythmia—Doxorubicin—uterine cancer	0.000171	0.000289	CcSEcCtD
Isotretinoin—Vision blurred—Epirubicin—uterine cancer	0.000169	0.000287	CcSEcCtD
Isotretinoin—Alopecia—Doxorubicin—uterine cancer	0.000169	0.000286	CcSEcCtD
Isotretinoin—Mental disorder—Doxorubicin—uterine cancer	0.000167	0.000284	CcSEcCtD
Isotretinoin—Ill-defined disorder—Epirubicin—uterine cancer	0.000167	0.000283	CcSEcCtD
Isotretinoin—Vomiting—Etoposide—uterine cancer	0.000166	0.000282	CcSEcCtD
Isotretinoin—Erythema—Doxorubicin—uterine cancer	0.000166	0.000282	CcSEcCtD
Isotretinoin—Malnutrition—Doxorubicin—uterine cancer	0.000166	0.000282	CcSEcCtD
Isotretinoin—Anaemia—Epirubicin—uterine cancer	0.000166	0.000282	CcSEcCtD
Isotretinoin—Agitation—Epirubicin—uterine cancer	0.000165	0.00028	CcSEcCtD
Isotretinoin—RARG—Gene Expression—ESR1—uterine cancer	0.000165	0.0006	CbGpPWpGaD
Isotretinoin—Rash—Etoposide—uterine cancer	0.000165	0.00028	CcSEcCtD
Isotretinoin—Dermatitis—Etoposide—uterine cancer	0.000165	0.00028	CcSEcCtD
Isotretinoin—Headache—Etoposide—uterine cancer	0.000164	0.000278	CcSEcCtD
Isotretinoin—Flatulence—Doxorubicin—uterine cancer	0.000164	0.000278	CcSEcCtD
Isotretinoin—Tension—Doxorubicin—uterine cancer	0.000163	0.000277	CcSEcCtD
Isotretinoin—Malaise—Epirubicin—uterine cancer	0.000162	0.000275	CcSEcCtD
Isotretinoin—Nervousness—Doxorubicin—uterine cancer	0.000162	0.000274	CcSEcCtD
Isotretinoin—Syncope—Epirubicin—uterine cancer	0.000161	0.000273	CcSEcCtD
Isotretinoin—Back pain—Doxorubicin—uterine cancer	0.000161	0.000273	CcSEcCtD
Isotretinoin—Palpitations—Epirubicin—uterine cancer	0.000159	0.000269	CcSEcCtD
Isotretinoin—Loss of consciousness—Epirubicin—uterine cancer	0.000158	0.000268	CcSEcCtD
Isotretinoin—Cough—Epirubicin—uterine cancer	0.000157	0.000266	CcSEcCtD
Isotretinoin—Vision blurred—Doxorubicin—uterine cancer	0.000157	0.000266	CcSEcCtD
Isotretinoin—Convulsion—Epirubicin—uterine cancer	0.000156	0.000264	CcSEcCtD
Isotretinoin—Nausea—Etoposide—uterine cancer	0.000155	0.000264	CcSEcCtD
Isotretinoin—Hypertension—Epirubicin—uterine cancer	0.000155	0.000263	CcSEcCtD
Isotretinoin—Ill-defined disorder—Doxorubicin—uterine cancer	0.000154	0.000262	CcSEcCtD
Isotretinoin—Anaemia—Doxorubicin—uterine cancer	0.000154	0.000261	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—ESR1—uterine cancer	0.000154	0.000559	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—POLD1—uterine cancer	0.000153	0.000558	CbGpPWpGaD
Isotretinoin—Chest pain—Epirubicin—uterine cancer	0.000153	0.00026	CcSEcCtD
Isotretinoin—Arthralgia—Epirubicin—uterine cancer	0.000153	0.00026	CcSEcCtD
Isotretinoin—Myalgia—Epirubicin—uterine cancer	0.000153	0.00026	CcSEcCtD
Isotretinoin—Agitation—Doxorubicin—uterine cancer	0.000153	0.000259	CcSEcCtD
Isotretinoin—Anxiety—Epirubicin—uterine cancer	0.000152	0.000259	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000152	0.000258	CcSEcCtD
Isotretinoin—Discomfort—Epirubicin—uterine cancer	0.000151	0.000256	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—ESR1—uterine cancer	0.000151	0.000549	CbGpPWpGaD
Isotretinoin—Malaise—Doxorubicin—uterine cancer	0.00015	0.000254	CcSEcCtD
Isotretinoin—Dry mouth—Epirubicin—uterine cancer	0.00015	0.000254	CcSEcCtD
Isotretinoin—Syncope—Doxorubicin—uterine cancer	0.000149	0.000253	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000149	0.000541	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ESR1—uterine cancer	0.000148	0.000538	CbGpPWpGaD
Isotretinoin—Confusional state—Epirubicin—uterine cancer	0.000148	0.000251	CcSEcCtD
Isotretinoin—Palpitations—Doxorubicin—uterine cancer	0.000147	0.000249	CcSEcCtD
Isotretinoin—Anaphylactic shock—Epirubicin—uterine cancer	0.000147	0.000249	CcSEcCtD
Isotretinoin—Oedema—Epirubicin—uterine cancer	0.000147	0.000249	CcSEcCtD
Isotretinoin—Loss of consciousness—Doxorubicin—uterine cancer	0.000146	0.000248	CcSEcCtD
Isotretinoin—Infection—Epirubicin—uterine cancer	0.000146	0.000247	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—MET—uterine cancer	0.000145	0.000528	CbGpPWpGaD
Isotretinoin—Cough—Doxorubicin—uterine cancer	0.000145	0.000246	CcSEcCtD
Isotretinoin—Shock—Epirubicin—uterine cancer	0.000144	0.000245	CcSEcCtD
Isotretinoin—Convulsion—Doxorubicin—uterine cancer	0.000144	0.000244	CcSEcCtD
Isotretinoin—Nervous system disorder—Epirubicin—uterine cancer	0.000144	0.000244	CcSEcCtD
Isotretinoin—Thrombocytopenia—Epirubicin—uterine cancer	0.000144	0.000244	CcSEcCtD
Isotretinoin—Hypertension—Doxorubicin—uterine cancer	0.000144	0.000244	CcSEcCtD
Isotretinoin—RXRA—Metabolism—AKR1C1—uterine cancer	0.000144	0.000522	CbGpPWpGaD
Isotretinoin—Tachycardia—Epirubicin—uterine cancer	0.000143	0.000243	CcSEcCtD
Isotretinoin—Skin disorder—Epirubicin—uterine cancer	0.000142	0.000242	CcSEcCtD
Isotretinoin—RARA—Gene Expression—ESR1—uterine cancer	0.000142	0.000516	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ESR1—uterine cancer	0.000142	0.000516	CbGpPWpGaD
Isotretinoin—Hyperhidrosis—Epirubicin—uterine cancer	0.000142	0.000241	CcSEcCtD
Isotretinoin—Chest pain—Doxorubicin—uterine cancer	0.000142	0.00024	CcSEcCtD
Isotretinoin—Arthralgia—Doxorubicin—uterine cancer	0.000142	0.00024	CcSEcCtD
Isotretinoin—Myalgia—Doxorubicin—uterine cancer	0.000142	0.00024	CcSEcCtD
Isotretinoin—Anxiety—Doxorubicin—uterine cancer	0.000141	0.000239	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000141	0.000238	CcSEcCtD
Isotretinoin—Discomfort—Doxorubicin—uterine cancer	0.00014	0.000237	CcSEcCtD
Isotretinoin—Anorexia—Epirubicin—uterine cancer	0.00014	0.000237	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—PGR—uterine cancer	0.000139	0.000504	CbGpPWpGaD
Isotretinoin—Dry mouth—Doxorubicin—uterine cancer	0.000138	0.000235	CcSEcCtD
Isotretinoin—Hypotension—Epirubicin—uterine cancer	0.000137	0.000232	CcSEcCtD
Isotretinoin—Confusional state—Doxorubicin—uterine cancer	0.000137	0.000232	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000137	0.000497	CbGpPWpGaD
Isotretinoin—Oedema—Doxorubicin—uterine cancer	0.000136	0.00023	CcSEcCtD
Isotretinoin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000136	0.00023	CcSEcCtD
Isotretinoin—Infection—Doxorubicin—uterine cancer	0.000135	0.000229	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000134	0.000227	CcSEcCtD
Isotretinoin—Shock—Doxorubicin—uterine cancer	0.000134	0.000226	CcSEcCtD
Isotretinoin—Nervous system disorder—Doxorubicin—uterine cancer	0.000133	0.000226	CcSEcCtD
Isotretinoin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000133	0.000225	CcSEcCtD
Isotretinoin—Insomnia—Epirubicin—uterine cancer	0.000133	0.000225	CcSEcCtD
Isotretinoin—Tachycardia—Doxorubicin—uterine cancer	0.000132	0.000225	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000132	0.00048	CbGpPWpGaD
Isotretinoin—Skin disorder—Doxorubicin—uterine cancer	0.000132	0.000224	CcSEcCtD
Isotretinoin—Paraesthesia—Epirubicin—uterine cancer	0.000132	0.000223	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—EZH2—uterine cancer	0.000132	0.000478	CbGpPWpGaD
Isotretinoin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000131	0.000223	CcSEcCtD
Isotretinoin—Dyspnoea—Epirubicin—uterine cancer	0.000131	0.000222	CcSEcCtD
Isotretinoin—Somnolence—Epirubicin—uterine cancer	0.00013	0.000221	CcSEcCtD
Isotretinoin—Anorexia—Doxorubicin—uterine cancer	0.000129	0.000219	CcSEcCtD
Isotretinoin—Dyspepsia—Epirubicin—uterine cancer	0.000129	0.000219	CcSEcCtD
Isotretinoin—RXRA—Metabolism—RRM2—uterine cancer	0.000128	0.000465	CbGpPWpGaD
Isotretinoin—Decreased appetite—Epirubicin—uterine cancer	0.000128	0.000216	CcSEcCtD
Isotretinoin—Hypotension—Doxorubicin—uterine cancer	0.000127	0.000215	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000127	0.000215	CcSEcCtD
Isotretinoin—Fatigue—Epirubicin—uterine cancer	0.000126	0.000214	CcSEcCtD
Isotretinoin—Constipation—Epirubicin—uterine cancer	0.000125	0.000213	CcSEcCtD
Isotretinoin—Pain—Epirubicin—uterine cancer	0.000125	0.000213	CcSEcCtD
Isotretinoin—RXRA—Metabolism—DCN—uterine cancer	0.000124	0.000452	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000124	0.00021	CcSEcCtD
Isotretinoin—Insomnia—Doxorubicin—uterine cancer	0.000123	0.000208	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—ESR2—uterine cancer	0.000122	0.000444	CbGpPWpGaD
Isotretinoin—Paraesthesia—Doxorubicin—uterine cancer	0.000122	0.000207	CcSEcCtD
Isotretinoin—Dyspnoea—Doxorubicin—uterine cancer	0.000121	0.000205	CcSEcCtD
Isotretinoin—Feeling abnormal—Epirubicin—uterine cancer	0.000121	0.000205	CcSEcCtD
Isotretinoin—Somnolence—Doxorubicin—uterine cancer	0.000121	0.000205	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Epirubicin—uterine cancer	0.00012	0.000203	CcSEcCtD
Isotretinoin—Dyspepsia—Doxorubicin—uterine cancer	0.000119	0.000203	CcSEcCtD
Isotretinoin—Decreased appetite—Doxorubicin—uterine cancer	0.000118	0.0002	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000117	0.000199	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CYP11A1—uterine cancer	0.000117	0.000426	CbGpPWpGaD
Isotretinoin—Fatigue—Doxorubicin—uterine cancer	0.000117	0.000198	CcSEcCtD
Isotretinoin—Urticaria—Epirubicin—uterine cancer	0.000117	0.000198	CcSEcCtD
Isotretinoin—Constipation—Doxorubicin—uterine cancer	0.000116	0.000197	CcSEcCtD
Isotretinoin—Pain—Doxorubicin—uterine cancer	0.000116	0.000197	CcSEcCtD
Isotretinoin—Abdominal pain—Epirubicin—uterine cancer	0.000116	0.000197	CcSEcCtD
Isotretinoin—Body temperature increased—Epirubicin—uterine cancer	0.000116	0.000197	CcSEcCtD
Isotretinoin—Feeling abnormal—Doxorubicin—uterine cancer	0.000112	0.00019	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000112	0.000406	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000111	0.000188	CcSEcCtD
Isotretinoin—RXRA—Metabolism—AKR1C3—uterine cancer	0.000111	0.000402	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Epirubicin—uterine cancer	0.000108	0.000183	CcSEcCtD
Isotretinoin—Urticaria—Doxorubicin—uterine cancer	0.000108	0.000183	CcSEcCtD
Isotretinoin—Abdominal pain—Doxorubicin—uterine cancer	0.000107	0.000182	CcSEcCtD
Isotretinoin—Body temperature increased—Doxorubicin—uterine cancer	0.000107	0.000182	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—ERBB2—uterine cancer	0.000106	0.000386	CbGpPWpGaD
Isotretinoin—Asthenia—Epirubicin—uterine cancer	0.000105	0.000179	CcSEcCtD
Isotretinoin—Pruritus—Epirubicin—uterine cancer	0.000104	0.000176	CcSEcCtD
Isotretinoin—Diarrhoea—Epirubicin—uterine cancer	0.0001	0.00017	CcSEcCtD
Isotretinoin—Hypersensitivity—Doxorubicin—uterine cancer	0.0001	0.00017	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—CDKN2B—uterine cancer	9.93e-05	0.000361	CbGpPWpGaD
Isotretinoin—Asthenia—Doxorubicin—uterine cancer	9.74e-05	0.000165	CcSEcCtD
Isotretinoin—Dizziness—Epirubicin—uterine cancer	9.7e-05	0.000165	CcSEcCtD
Isotretinoin—Pruritus—Doxorubicin—uterine cancer	9.6e-05	0.000163	CcSEcCtD
Isotretinoin—Vomiting—Epirubicin—uterine cancer	9.33e-05	0.000158	CcSEcCtD
Isotretinoin—Diarrhoea—Doxorubicin—uterine cancer	9.29e-05	0.000158	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—CTNNB1—uterine cancer	9.29e-05	0.000338	CbGpPWpGaD
Isotretinoin—Rash—Epirubicin—uterine cancer	9.25e-05	0.000157	CcSEcCtD
Isotretinoin—Dermatitis—Epirubicin—uterine cancer	9.24e-05	0.000157	CcSEcCtD
Isotretinoin—Headache—Epirubicin—uterine cancer	9.19e-05	0.000156	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—SMAD3—uterine cancer	9.06e-05	0.00033	CbGpPWpGaD
Isotretinoin—Dizziness—Doxorubicin—uterine cancer	8.97e-05	0.000152	CcSEcCtD
Isotretinoin—Nausea—Epirubicin—uterine cancer	8.71e-05	0.000148	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—EP300—uterine cancer	8.63e-05	0.000314	CbGpPWpGaD
Isotretinoin—Vomiting—Doxorubicin—uterine cancer	8.63e-05	0.000146	CcSEcCtD
Isotretinoin—RXRA—Metabolism—STK11—uterine cancer	8.61e-05	0.000313	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP19A1—uterine cancer	8.61e-05	0.000313	CbGpPWpGaD
Isotretinoin—Rash—Doxorubicin—uterine cancer	8.56e-05	0.000145	CcSEcCtD
Isotretinoin—Dermatitis—Doxorubicin—uterine cancer	8.55e-05	0.000145	CcSEcCtD
Isotretinoin—Headache—Doxorubicin—uterine cancer	8.5e-05	0.000144	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—VEGFA—uterine cancer	8.17e-05	0.000297	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.08e-05	0.000294	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NRAS—uterine cancer	8.07e-05	0.000294	CbGpPWpGaD
Isotretinoin—Nausea—Doxorubicin—uterine cancer	8.06e-05	0.000137	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.71e-05	0.00028	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ESR1—uterine cancer	7.4e-05	0.000269	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KRAS—uterine cancer	6.95e-05	0.000253	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTHFR—uterine cancer	6.47e-05	0.000235	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—AKT1—uterine cancer	5.95e-05	0.000217	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HRAS—uterine cancer	5.91e-05	0.000215	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.7e-05	0.000207	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—AKT1—uterine cancer	5.44e-05	0.000198	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AKT1—uterine cancer	5.34e-05	0.000194	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—AKT1—uterine cancer	5.22e-05	0.00019	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—AKT1—uterine cancer	5.12e-05	0.000186	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—AKT1—uterine cancer	5.12e-05	0.000186	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTEN—uterine cancer	3.6e-05	0.000131	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—EP300—uterine cancer	3.43e-05	0.000125	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AKT1—uterine cancer	2.67e-05	9.7e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CA—uterine cancer	2.54e-05	9.24e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKT1—uterine cancer	2.07e-05	7.54e-05	CbGpPWpGaD
